Enzolytics Inc. (ENZC)
ENZC Stock Price Chart
Explore Enzolytics Inc. interactive price chart. Choose custom timeframes to analyze ENZC price movements and trends.
ENZC Company Profile
Discover essential business fundamentals and corporate details for Enzolytics Inc. (ENZC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
8 Apr 2009
Employees
1.00
Website
https://enzolytics.comCEO
Steven Sharabura
Description
Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, it has created a proprietary cell line that produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics Inc. is based in Plano, Texas.
ENZC Financial Timeline
Browse a chronological timeline of Enzolytics Inc. corporate events including earnings releases, dividend announcements, and stock splits.
ENZC Stock Performance
Access detailed ENZC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.